» Articles » PMID: 12529927

Tight Junctions of the Blood-brain Barrier: Development, Composition and Regulation

Overview
Date 2003 Jan 18
PMID 12529927
Citations 404
Authors
Affiliations
Soon will be listed here.
Abstract

1. The blood-brain barrier is essential for the maintenance and regulation of the neural microenvironment. The main characteristic features of blood-brain barrier endothelial cells are an extremely low rate of transcytotic vesicles and a restrictive paracellular diffusion barrier. 2. Endothelial blood-brain barrier tight junctions differ from epithelial tight junctions, not only by distinct morphological and molecular properties, but also by the fact that endothelial tight junctions are more sensitive to microenvironmental than epithelial factors. 3. Many ubiquitous molecular tight junction components have been identified and characterized including claudins, occludin, ZO-1, ZO-2, ZO-3, cingulin and 7H6. Signaling pathways involved in tight junction regulation include G-proteins, serine-, threonine- and tyrosine-kinases, extra and intracellular calcium levels, cAMP levels, proteases and cytokines. Common to most of these pathways is the modulation of cytoskeletal elements and the connection of tight junction transmembrane molecules to the cytoskeleton. Additionally, crosstalk between components of the tight junction- and the cadherin-catenin system of the adherens junction suggests a close functional interdependence of the two cell-cell contact systems. 4. Important new molecular aspects of tight junction regulation were recently elucidated. This review provides an integration of these new results.

Citing Articles

The Triad of Blood-Brain Barrier Integrity: Endothelial Cells, Astrocytes, and Pericytes in Perinatal Stroke Pathophysiology.

Garcia-Martinez T, Gornatti D, Ortiz M, Canellas G, Heine-Suner D, Vives-Bauza C Int J Mol Sci. 2025; 26(5).

PMID: 40076511 PMC: 11900453. DOI: 10.3390/ijms26051886.


Regulation of BzATP-Induced Blood-Brain Barrier Endothelial Cell Hyperpermeability by NLRP3 Inflammasome Inhibition.

Anderson A, Waithe O, Seplovich G, Olagunju O, Greene C, Singh A Microcirculation. 2025; 32(3):e70006.

PMID: 40052959 PMC: 11905927. DOI: 10.1111/micc.70006.


Blood-Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions.

Zhang F, Zhang J, Wang X, Han M, Fei Y, Wang J Int J Mol Sci. 2025; 26(3).

PMID: 39940642 PMC: 11817713. DOI: 10.3390/ijms26030873.


Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook.

Patel S, Salaman S, Kapoor D, Yadav R, Sharma S Z Naturforsch C J Biosci. 2024; .

PMID: 39566511 DOI: 10.1515/znc-2024-0208.


The role of autophagy in brain health and disease: Insights into exosome and autophagy interactions.

Wang H, Lv C, Feng L, Guo J, Zhao S, Jiang P Heliyon. 2024; 10(21):e38959.

PMID: 39524893 PMC: 11546156. DOI: 10.1016/j.heliyon.2024.e38959.